Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

Tamoxifen for early breast cancer: an overview of the randomised trials

The Lancet · 1998 · 4.1K citations

Breast Oncology, Early Breast Cancer, Medicine +10

Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

Lisa A. Carey, Charles M. Perou, Chad Livasy et al. · JAMA · 2006 · 3.8K citations

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

Maggie C.U. Cheang, David Voduc, Chris Bajdik et al. · Clinical Cancer Research · 2008 · 1.2K citations · Full text

Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy

Paul L. Nguyen, Alphonse G. Taghian, Matthew S. Katz et al. · Journal of Clinical Oncology · 2008 · 816 citations · Full text

The value of estrogen and progesterone receptors in the treatment of breast cancer

C. Kent Osborne, Michael G. Yochmowitz, William A. Knight et al. · Cancer · 1980 · 725 citations · Full text

Breast Oncology, Progesterone Receptors, Medicine +14